Bea C. Tanis
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
Journal: Leukemia
Published: June 30, 2023
Donor variation in stored platelets: Higher metabolic rates of platelets are associated with mean platelet volume, activation and donor health.
Journal: Transfusion
Published: June 09, 2022
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
Journal: British journal of cancer
Published: March 12, 2020
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Journal: Cancer medicine
Published: March 05, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 17, 2018
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Journal: Blood
Published: December 27, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2017
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 14, 2016
Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 26, 2015
Last Updated: 09/26/2026